Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13.
Zeng, Mei
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13. [electronic resource] - eLife 11 2018
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
2050-084X
10.7554/eLife.39030 doi
Animals
Antineoplastic Agents--administration & dosage
CDC2 Protein Kinase--antagonists & inhibitors
Cell Line, Tumor
Cyclin-Dependent Kinases--antagonists & inhibitors
Disease Models, Animal
Down-Regulation
Enzyme Inhibitors--administration & dosage
Female
Heterografts
Humans
Mice, SCID
Neoplasm Transplantation
Ovarian Neoplasms--drug therapy
Phenylenediamines--administration & dosage
Proto-Oncogene Proteins c-myc--biosynthesis
Pyrimidines--administration & dosage
Treatment Outcome
Cyclin-Dependent Kinase-Activating Kinase
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13. [electronic resource] - eLife 11 2018
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
2050-084X
10.7554/eLife.39030 doi
Animals
Antineoplastic Agents--administration & dosage
CDC2 Protein Kinase--antagonists & inhibitors
Cell Line, Tumor
Cyclin-Dependent Kinases--antagonists & inhibitors
Disease Models, Animal
Down-Regulation
Enzyme Inhibitors--administration & dosage
Female
Heterografts
Humans
Mice, SCID
Neoplasm Transplantation
Ovarian Neoplasms--drug therapy
Phenylenediamines--administration & dosage
Proto-Oncogene Proteins c-myc--biosynthesis
Pyrimidines--administration & dosage
Treatment Outcome
Cyclin-Dependent Kinase-Activating Kinase